Unknown

Dataset Information

0

Methanolic Phoenix dactylifera L. Extract Ameliorates Cisplatin-Induced Hepatic Injury in Male Rats.


ABSTRACT: This study investigated the ameliorative potential of methanolic date flesh extract (MDFE) against cisplatin-induced hepatic injury. Twenty male rats (weighing 180-200 g) were allocated into four groups: control; date flesh (DF) group (oral 600 mg/kg MDFE for 21 days); Cis group (7.5 mg/kg i.p. at day 16); and date flesh/cisplatin (DF/Cis) group (oral 600 mg/kg MDFE for 21 days and 7.5 mg/kg i.p. at day 16). Hepatic biochemical parameters in sera, and inflammatory and oxidant/antioxidant hepatic biomarkers were estimated. Hepatic histological changes and the immunohistochemistry of cyclooxygenase-2 (COX-2), nuclear factor kappa B (NF-κB), and alpha smooth muscle actin (α-SMA) were assessed. Pretreatment with MDFE decreased Cis-triggered liver biochemical parameters, oxidative stress, inflammatory biomarkers, and histological damage. Moreover, MDFE treatment reduced Cis-induced hepatic NF-κB, COX-2, and α-SMA protein expression. MDFE exerted a hepatoprotective effect when used concomitantly with Cis. Its effect was mediated via its antioxidant and anti-inflammatory ingredients.

SUBMITTER: Gad El-Hak HN 

PROVIDER: S-EPMC8912432 | biostudies-literature | 2022 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Methanolic <i>Phoenix dactylifera</i> L. Extract Ameliorates Cisplatin-Induced Hepatic Injury in Male Rats.

Gad El-Hak Heba Nageh HN   Mahmoud Hany Salah HS   Ahmed Eman A EA   Elnegris Heba M HM   Aldayel Tahany Saleh TS   Abdelrazek Heba M A HMA   Soliman Mohamed T A MTA   El-Menyawy Menna Allah I MAI  

Nutrients 20220228 5


This study investigated the ameliorative potential of methanolic date flesh extract (MDFE) against cisplatin-induced hepatic injury. Twenty male rats (weighing 180-200 g) were allocated into four groups: control; date flesh (DF) group (oral 600 mg/kg MDFE for 21 days); Cis group (7.5 mg/kg i.p. at day 16); and date flesh/cisplatin (DF/Cis) group (oral 600 mg/kg MDFE for 21 days and 7.5 mg/kg i.p. at day 16). Hepatic biochemical parameters in sera, and inflammatory and oxidant/antioxidant hepatic  ...[more]

Similar Datasets

| S-EPMC7792057 | biostudies-literature
| S-EPMC6773839 | biostudies-literature
| PRJNA615979 | ENA
| PRJNA291215 | ENA
| PRJNA505138 | ENA
| PRJNA505141 | ENA
| PRJNA472694 | ENA
| PRJNA584693 | ENA
| PRJNA584696 | ENA
| PRJDB17453 | ENA